benserazide has been researched along with MS (Multiple Sclerosis) in 2 studies
Benserazide: An inhibitor of DOPA DECARBOXYLASE that does not enter the central nervous system. It is often given with LEVODOPA in the treatment of parkinsonism to prevent the conversion of levodopa to dopamine in the periphery, thereby increasing the amount that reaches the central nervous system and reducing the required dose. It has no antiparkinson actions when given alone.
benserazide : A carbohydrazide that results from the formal condensation of the carboxy group of DL-serine with the primary amino group of 4-(hydrazinylmethyl)benzene-1,2,3-triol. An aromatic-L-amino-acid decarboxylase inhibitor (DOPA decarboxylase inhibitor) that does not enter the central nervous system, it is used as its hydrochloride salt as an adjunct to levodopa in the treatment of parkinsonism. By preventing the conversion of levodopa to dopamine in the periphery, it causes an increase in the amount of levodopa reaching the central nervous system and so reduces the required dose. Benserazide has no antiparkinson actions when given alone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evans, AH | 1 |
| Butzkueven, H | 1 |
| Hyyppä, MT | 1 |
| Jolma, T | 1 |
| Riekkinen, P | 1 |
| Rinne, UK | 1 |
1 trial available for benserazide and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Effects of L-tryptophan treatment on central indoleamine metabolism and short-lasting neurologic disturbances in multiple sclerosis.
Topics: Adult; Benserazide; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Middle Aged; Multiple Scler | 1975 |
1 other study available for benserazide and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis.
Topics: Adult; Benserazide; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Drug Ther | 2007 |